Danielj Rader News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The National Lipid Association Scientific Sessions will be held Thursday to Sunday and will spotlight emerging areas of research such as “cardio-rheumatology,” a renewed push to reinstate LDL as a health system quality metric and more. Christie M. Ballantyne, MD, FACC, FACP, FAHA, FNLA, chief of the section of cardiovascular research and professor of medicine at Baylor College of

The AHA celebrates 100 years of lifesaving work by announcing the recipients of its prestigious Merit Award.

A physician-scientist from Massachusetts researching whether chemicals naturally occurring in foods could help treat heart disease, a genetics expert from Pennsylvania exploring the molecular mechanisms of lipid metabolism and cardiovascular diseases and a California-based professor of cardiovascular medicine studying how vaping impacts the development of abdominal aortic aneurysms are the most recent American Heart Association Merit Award recipients.

Penn Medicine announced that it has received a $9.7 million grant that will be used to fund continuing education and training for genetic counselors. In a press release, Penn Medicine noted that further training will allow genetic counselors to “learn about specific hereditary disorders, assess risks, and make proactive decisions in areas from cancer prevention to family planning,”

Press release content from PR Newswire. The AP news staff was not involved in its creation. FDA Approves First-in-class Evkeeza™ (evinacumab-dgnb) for Patients with Ultra-rare Inherited Form of High Cholesterol February 11, 2021 GMT TARRYTOWN, N.Y., Feb. 11, 2021 /PRNewswire/ -- Homozygous familial hypercholesterolemia (HoFH) is an ultra-rare inherited condition that affects approximately 1,300 patients in the U.S. and is characterized by extremely high low-density lipoprotein cholesterol (LDL-C) In pivotal Phase 3 HoFH trial, adding Evkeeza to standard lipid-lowering therapies reduced LDL-...